sorafenib zentiva 200 mg tabletki powlekane
zentiva, k.s. - sorafenibi tosilas - tabletki powlekane - 200 mg
sorafenib mylan 200 mg tabletki powlekane
mylan ireland limited - sorafenibum - tabletki powlekane - 200 mg
sorafenib pharmascience 200 mg tabletki powlekane
pharmascience international limited - sorafenibum - tabletki powlekane - 200 mg
sorafenib sandoz 400 mg tabletki powlekane
sandoz gmbh - sorafenibi tosilas - tabletki powlekane - 400 mg
sorafenib stada 200 mg tabletki powlekane
stada arzneimittel ag - sorafenibum - tabletki powlekane - 200 mg
sorafenib stada 400 mg tabletki powlekane
stada arzneimittel ag - sorafenibi tosilas - tabletki powlekane - 400 mg
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - Środki przeciwnowotworowe - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
ipp 40 mg proszek do sporządzania roztworu do wstrzykiwań
sandoz gmbh - pantoprazolum - proszek do sporządzania roztworu do wstrzykiwań - 40 mg
ozzion 40 mg tabletki dojelitowe
zentiva, k.s. - pantoprazolum - tabletki dojelitowe - 40 mg
ozzion 20 mg tabletki dojelitowe
zentiva, k.s. - pantoprazolum - tabletki dojelitowe - 20 mg